Related Experiment Video
Updated: Mar 8, 2026
11:26
Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
9.2K
Sex Differences in Metabolic Cardiomyopathy
Cardiovascular Research
|February 4, 2017
Summary
Diabetic cardiomyopathies disproportionately affect women. This review explores sex-based differences in metabolism, calcium handling, and nitric oxide signaling pathways contributing to this disparity in heart disease.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Disorders
Background:
- Diabetic cardiomyopathies are more prevalent in women than men, unlike ischemic cardiomyopathies.
- Diabetes increases cardiovascular disease risk, with a notable sexual dimorphism: heart disease is 5x more common in diabetic women vs. 2x in diabetic men.
- Heart failure with preserved ejection fraction, linked to metabolic syndrome, is also more common in women.
Purpose of the Study:
- To review potential mechanisms underlying sex differences in metabolic cardiomyopathies.
- To evaluate sex differences in metabolism, calcium handling, nitric oxide, and structural proteins.
- To focus on signaling pathways, specifically nitric oxide synthase and PPARα, in regulating these sex differences.
Main Methods:
- Literature review of studies investigating sex differences in metabolic cardiomyopathies.
- Evaluation of sex-specific alterations in cardiac metabolism.
- Assessment of sex-based differences in calcium handling and nitric oxide pathways.
Main Results:
- Women exhibit distinct metabolic profiles and calcium handling in the context of diabetes.
- Nitric oxide synthase and PPARα signaling pathways show sex-dependent regulation.
- These pathways are implicated in the development of cardiac hypertrophy and heart failure in a sex-specific manner.
Conclusions:
- Sex differences in metabolism, calcium handling, and nitric oxide signaling contribute to the higher prevalence of diabetic cardiomyopathies in women.
- Targeting sex-specific pathways like nitric oxide synthase and PPARα may offer novel therapeutic strategies for diabetic heart disease.
- Understanding these sex differences is crucial for developing effective, personalized treatments for metabolic cardiomyopathies.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
593
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
01:25Cardiomyopathy I: Introduction and Classification
722
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722
01:30Cardiomyopathy II: Dilated Cardiomyopathy
689
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
694
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
694
01:29Cardiomyopathy V: Interprofessional Care
564
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
01:27Specialized Characteristics of Cardiac Muscles
4.6K
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
4.6K